Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

Nicoll, James A.R., Wilkinson, David, Holmes, Clive, Steart, Phil, Markham, Hannah, Weller, Roy O.·2003·Nature Medicine

DOI 10.1038/nm840

Cited by (1,000)

Items 701–800 of 1,000

Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Aβ1–6: Toward safer and effective vaccines against Alzheimer’s disease
Hong‐Duck Kim, J. Adam Maxwell, Fan-Kun Kong, De-chu Christopher Tang, Ken-ichiro Fukuchi · 2005 · Biochemical and Biophysical Research Communications
The Impact of Anti-Amyloid Immunotherapies on Stroke Care
Philippe‐Antoine Bilodeau, John R. Dickson, Mariel G. Kozberg · 2024 · Journal of Clinical Medicine
Inhibition of an Alzheimer’s disease–associated form of necroptosis rescues neuronal death in mouse models
Marta J. Koper, Sebastiaan Moonen, Alicja Ronisz, Simona Ospitalieri, Zsuzsanna Callaerts‐Vegh, Dries T’Syen, Sabine Rabe, Matthias Staufenbiel, Bart De Strooper, Sriram Balusu et al. · 2024 · Science Translational Medicine
Perspectives on Inhibiting β‐Amyloid Aggregation through Structure‐Based Drug Design
Pankaj Mishra, Senthil Raja Ayyannan, Gautam Panda · 2015 · ChemMedChem
Recombinant influenza A viruses as vaccine vectors
Thomas H. Gerlach, Husni Elbahesh, Giulietta Saletti, Guus F. Rimmelzwaan · 2019 · Expert Review of Vaccines
Alzheimer’s Disease: Lessons Learned from Amyloidocentric Clinical Trials
Andreas Soejitno, Anastasia Tjan, Thomas Eko Purwata · 2015 · CNS Drugs
Rationale for Peptide and DNA Based Epitope Vaccines for Alzheimers Disease Immunotherapy
Anahit Ghochikyan · 2009 · CNS & Neurological Disorders - Drug Targets
Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles
Marika Doucet, Aadil El-Turabi, Franziska Zabel, Benjamin H.M. Hunn, Nora Bengoa‐Vergniory, Milena Cioroch, Mauricio Ramm, Amy M. Smith, Ariane Cruz Gomes, Gustavo Cabral de Miranda et al. · 2017 · PLoS ONE
Production of an anti-Aβ antibody fragment in Pichia pastoris and in vitro and in vivo validation of its therapeutic effect
Laia Montoliu‐Gaya, Gisela Esquerda-Canals, Sílvia Bronsoms, Sandra Villegas · 2017 · PLoS ONE
Suppression of Aβ deposition in brain by peripheral administration of Fab fragments of anti-seed antibody
Naoki Yamamoto, Tatsuki Yokoseki, Masao Suzuki Shibata, Haruyasu Yamaguchi, Katsuhiko Yanagisawa · 2005 · Biochemical and Biophysical Research Communications
Amyloid β and Alzheimer disease therapeutics: the devil may be in the details
John R. Cirrito, David M. Holtzman · 2003 · Journal of Clinical Investigation
Toward an Early Diagnosis and Treatment of Alzheimer’s Disease
Agneta K. Nordberg · 2003 · International Psychogeriatrics
Refinement of a DNA based Alzheimer disease epitope vaccine in rabbits
Anahit Ghochikyan, Hayk Davtyan, Irina Petrushina, Armine Hovakimyan, Nina Movsesyan, Arpine Davtyan, Anatoly B. Kiyatkin, David H. Cribbs, Michael G. Agadjanyan · 2013 · Human Vaccines & Immunotherapeutics
Development of a Multicomponent Intervention to Prevent Alzheimer's Disease
Satoshi Saitô, Yumi Yamamoto, Masafumi Ihara · 2019 · Frontiers in Neurology
Antibody-based therapies for Huntington’s disease: current status and future directions
Hélèna L. Denis, Linda Suzanne David, Francesca Cicchetti · 2019 · Neurobiology of Disease
Central amyloid- -specific single chain variable fragment ameliorates A aggregation and neurotoxicity
Rebecca M. Nisbet, Julie Nigro, Kerry Breheney, Joanne M. Caine, Meghan K. Hattarki, Stewart D. Nuttall · 2013 · Protein Engineering Design and Selection
Alzheimer′s disease: A review of recent developments
FK Salawu, JoelT Umar, AbdulfataiB Olokoba · 2011 · Annals of African Medicine
Aβ43 in human Alzheimer’s disease: effects of active Aβ42 immunization
Lieke Jäkel, Delphine Boche, James A. R. Nicoll, Marcel M. Verbeek · 2019 · Acta Neuropathologica Communications
Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer’s Disease
Masashi Tanaka, Satoshi Saitô, Takayuki Inoue, Noriko Satoh‐Asahara, Masafumi Ihara · 2020 · International Journal of Molecular Sciences
Expression, purification, and characterization of recombinant human β-amyloid42 peptide in Escherichia coli
Li Zhang, Huixin Yu, Cuicui Song, Xiufeng Lin, Bo Chen, Chen Tan, Guo-xian Cao, Zhengwu Wang · 2008 · Protein Expression and Purification
Deglycosylated anti‐amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration
Kazuyuki Takata, Chiho Hirata‐Fukae, Amanda G. Becker, Saori Chishiro, Audrey J. Gray, Kouhei Nishitomi, Andreas H. Franz, Gaku Sakaguchi, Akira Kato, Mark P. Mattson et al. · 2007 · European Journal of Neuroscience
Blood-Based Protein Biomarkers for Diagnosis and Classification of Neurodegenerative Diseases
Carmen Noelker, Harald Juergen Hampel, Richard C. Dodel · 2011 · Molecular Diagnosis & Therapy
Consideration of the ischaemic basis and treatment of Alzheimer's disease.
Ryszard M. Pluta, Marzena Ułamek, Mirosław Jabłoński · 2010 · PubMed
Emerging therapeutics for Alzheimer’s disease
Emma R. L. C. Vardy, Ishrut Hussain, Nigel M. Hooper · 2006 · Expert Review of Neurotherapeutics
Passive Immunization of the Aβ42(43) C-Terminal-Specific Antibody BC05 in a Mouse Model of Alzheimer’s Disease
Asano Asami-Odaka, Yuka Obayashi-Adachi, Yoshio Matsumoto, Hideki Takahashi, Hiroaki Fukumoto, Takashi Horiguchi, Nobuhiro Suzuki, Mikio Shoji · 2005 · Neurodegenerative Diseases
New developments in mild cognitive impairment and Alzheimer's disease
Jonathan M. Schott, Jonathan Kennedy, Nick C. Fox · 2006 · Current Opinion in Neurology
Prevention of age-associated dementia
M. Hasan Mohajeri, Geneviève Leuba · 2009 · Brain Research Bulletin
CD40L disruption enhances Aβ vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation
Demian F. Obregon, H-Y Hou, Yun Bai, William V. Nikolic, Takashi Mori, Deyan Luo, J. Zeng, Jared C. Ehrhart, F. Fernandez, D. Morgan et al. · 2007 · Neurobiology of Disease
Antibodies to Potato Virus Y Bind the Amyloid β Peptide
Robert Paul Friedland, Johnathan M. Tedesco, Andrea C. Wilson, Craig Atwood, Mark A. Smith, George L. Perry, Michael G. Zagorski · 2008 · Journal of Biological Chemistry
Endothelial expression of human amyloid precursor protein leads to amyloid β in the blood and induces cerebral amyloid angiopathy in knock-in mice
Yuriko Tachida, Saori Miura, Rie Imamaki, Naomi Ogasawara, Hiroyuki Takuwa, Naruhiko Sahara, Akihiro Shindo, Yukio Matsuba, Takashi Saito, Naoyuki Taniguchi et al. · 2022 · Journal of Biological Chemistry
Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go?
Rommy von Bernhardi M. · 2010 · Journal of Alzheimer s Disease
Immune Activation in Amyloid-β-Related Angiitis Correlates with Decreased Parenchymal Amyloid-β Plaque Load
Simon Bogner, Christian Bernreuther, Jakob Matschke, Alvaro A. Barrera-Ocampo, Diego Sepúlveda Falla, Frank Leypoldt, Tim Ullrich Magnus, F. Haag, Markus Bergmann, Wolfgang Brück et al. · 2013 · Neurodegenerative Diseases
Novel Aβ Immunogens: Is Shorter Better?
Cynthia Ann Lemere, Marcel Maier, Ying Peng, Liying Jiang, Timothy J. Seabrook · 2007 · Current Alzheimer Research
CCR2/CCL2-mediated inflammation protects photoreceptor cells from amyloid-β-induced apoptosis
Julien Bruban, Agathe Maoui, Naïma Chalour, Na An, Laurent Jonet, Charles Feumi, Jacques Tréton, Florian Sennlaub, Francine Béhar‐Cohen, Frédéric Mascarelli et al. · 2011 · Neurobiology of Disease
APP transgenic mice: The effect of active and passive immunotherapy in cognitive tasks
Stephan Röskam, Frauke Neff, Rainer K.W. Schwarting, Michael Bacher, Richard C. Dodel · 2009 · Neuroscience & Biobehavioral Reviews
Clinically tested drugs for Alzheimer?s disease
Edith G. McGeer, Patrick L. McGeer · 2003 · Expert Opinion on Investigational Drugs
Altered T-cell reactivity in the early stages of Alzheimer's disease
Rickenbach, Chiara, Mallone, Anna, Häusle, Lars, Frei, Larissa, Seiter, Sarina, Sparano, Colin, Kirabali, Tunahan, Blennow, Kaj, Zetterberg, Henrik, Ferretti, Maria Teresa et al. · 2025 · Brain
Donanemab for Alzheimer’s disease: from preclinical research to the clinical application
Richard C. Dodel, Lutz Froelich · 2025 · Expert Review of Neurotherapeutics
Investigational medications for treatment of patients with Alzheimer disease.
Pamela E. Potter · 2010 · PubMed
Development of a New DNA Vaccine for Alzheimer Disease Targeting a Wide Range of Aβ Species and Amyloidogenic Peptides
Yoh Matsumoto, Naoko Niimi, Kuniko Kohyama · 2013 · PLoS ONE
Prophylaxis and Treatment of Alzheimer's Disease by Delivery of an Adeno-Associated Virus Encoding a Monoclonal Antibody Targeting the Amyloid Beta Protein
Masaru Shimada, Shinya Abe, Toru Takahashi, Kazumasa Shiozaki, Mitsue Okuda, Hiroaki Mizukami, Dennis M. Klinman, Keiya Ozawa, Kenji Okuda · 2013 · PLoS ONE
Vaccine Development to Treat Alzheimer’s Disease Neuropathology in APP/PS1 Transgenic Mice
Iván Carrera, Ignacio Etcheverrı́a, L. Fernández‐Novoa, Valter Lombardi, Ramón Cacabelos, Carmen Vigo · 2012 · International Journal of Alzheimer s Disease
Targets and Mechanisms in Prevention of Parkinson's Disease through Immunomodulatory Treatments
Marianne von Euler Chelpin, Thomas Vorup‐Jensen · 2017 · Scandinavian Journal of Immunology
Convergent molecular defects underpin diverse neurodegenerative diseases
George K. Tofaris, Noel J. Buckley · 2018 · Journal of Neurology Neurosurgery & Psychiatry
Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic acid synthetic complex
Moon‐Hee Lee, Jian‐Ping Guo, Claudia Schwab, Edith G. McGeer, Patrick L. McGeer · 2012 · Neurobiology of Aging
Tg-SwDI Transgenic Mice Exhibit Novel Alterations in AβPP Processing, Aβ Degradation, and Resilient Amyloid Angiopathy
Gregory D. Van Vickle, Chera L. Esh, Ian D. Daugs, Tyler A. Kokjohn, Walter M. Kalback, Rebekah Patton, Dean C. Luehrs, Douglas G. Walker, Lih‐Fen Lue, Thomas G. Beach et al. · 2008 · American Journal Of Pathology
Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-modifying Drugs
Wolfgang Froestl, Andrea Pfeifer, Andreas Muhs · 2013 · Journal of Alzheimer s Disease
Evidence supporting a role for anti-Aβ antibodies in the treatment of Alzheimer’s disease
David Morgan, Bruce D. Gitter · 2004 · Neurobiology of Aging
A manifesto for Alzheimer’s disease drug discovery in the era of disease-modifying therapies
Heike Hering, Thierry Bussière, Chia‐Chen Liu, Kelly E. Glajch, Andreas Weihofen, Jane L. Grogan, Dominic M. Walsh · 2025 · Molecular Neurodegeneration
Aducanumab in Alzheimer’s Disease: A Critical Update
Sumel Ashique, Ekta Sirohi, Shubneesh Kumar, Mohd Rihan, Neeraj Mishra, Shvetank Bhatt, Rupesh Kumar Gautam, Sachin Kumar Singh, Gaurav Gupta, Dinesh Kumar Chellappan et al. · 2023 · Current Medicinal Chemistry
Aβ vaccination in combination with behavioral enrichment in aged beagles: effects on cognition, Aβ, and microhemorrhages
Paulina R. Davis, Ginevra Giannini, Karin Rudolph, Nathaniel T. Calloway, Christopher M. Royer, Tina L. Beckett, M. Paul Murphy, Frederick Bresch, Dieter Pagani, Thomas L Platt et al. · 2016 · Neurobiology of Aging
A short perspective on the long road to effective treatments for Alzheimer's disease
David S. Reynolds · 2019 · British Journal of Pharmacology
Imaging and In Vivo Quantitation of β-Amyloid: An Exemplary Biomarker for Alzheimer’s Disease?
Lisa M. Nichols, Victor W. Pike, Lisheng Cai, Robert B. Innis · 2006 · Biological Psychiatry
Current Concepts and Future Prospects for Alzheimer Disease Vaccines
Frank L. Heppner, Sam Gandy, JoAnne McLaurin · 2004 · Alzheimer Disease & Associated Disorders
Toward modeling hemorrhagic and encephalitic complications of Alzheimer amyloid-β vaccination in nonhuman primates
Sam Gandy, Lary C. Walker · 2004 · Current Opinion in Immunology
Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases
Luke McAlary, Steven Samuel Plotkin, Neil R. Cashman · 2019 · CNS Drugs
Peri‐arterial pathways for clearance of α‐Synuclein and tau from the brain: Implications for the pathogenesis of dementias and for immunotherapy
Jacqui Nimmo, David Annandale Johnston, Jean‐Cosme Dodart, Matthew MacGregor Sharp, Roy O. Weller, James A. R. Nicoll, Ajay Kumar Verma, Roxana Octavia Carare · 2020 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
The RSNA QIBA Profile for Amyloid PET as an Imaging Biomarker for Cerebral Amyloid Quantification
Anne M. Smith, Nancy A. Obuchowski, Norman L. Foster, Gregory Klein, P. David Mozley, Adriaan A. Lammertsma, Richard L. Wahl, John J. Sunderland, Jean‐Luc Vanderheyden, Tammie L.S. Benzinger et al. · 2022 · Journal of Nuclear Medicine
Aβ-degrading proteases:therapeutic potential in Alzheimer disease
M. Leissring · 2016 · CNS Drugs
Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center
John Hanfelt, Limin Peng, Felicia C. Goldstein, James J. Lah · 2018 · Neurobiology of Disease
Immune effects of optimized DNA vaccine and protective effects in a MPTP model of Parkinson’s disease
Zhongmei Chen, Yunpeng Yang, Yang Xu, Changqing Zhou, Fengqun Li, Lei Peng, Ling Zhong, Xin Jin, Guo‐Guang Peng · 2013 · Neurological Sciences
Cerebral amyloid angiopathy: Both viper and maggot in the brain
Roy O. Weller, James A. R. Nicoll · 2005 · Annals of Neurology
Early diagnostics and therapeutics for Alzheimer’s disease – how early can we get there?
Bernhard Hans Monien, Liana G. Apostolova, Gal Bitan · 2006 · Expert Review of Neurotherapeutics
MHC-Independent Genetic Factors Control the Magnitude of CD4+ T Cell Responses to Amyloid-β Peptide in Mice through Regulatory T Cell-Mediated Inhibition
Cécile Toly‐Ndour, Gabrielle Lui, Maria Manuel Nunes, M. Bruley-Rosset, Pièrre Aucouturier, Guillaume Dorothée · 2011 · The Journal of Immunology
The immunotherapy of Alzheimer's disease
Marc E. Weksler · 2004 · Immunity & Ageing
Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease
Sumner, Isabelle L., Edwards, Ross A., Asuni, Ayodeji A., Teeling, Jessica L. · 2018 · Frontiers in Neuroscience
Processo Inflamatório e Neuroimunomodulação na Doença de Alzheimer
Natália Pessoa Rocha, Luiza da Conceição Amorim Martins, Antônio Lúcio Teixeira, Helton José Reis · 2001 · Revista Neurociências
CD8+ T cells exacerbate AD-like symptoms in mouse model of amyloidosis
Xin Wang, Britney Campbell, Monica Bodogai, Ross A. McDevitt, Anton Patrikeev, Fedor E. Gusev, Emeline Ragonnaud, Konda Kumaraswami, Sophie D. Shirenova, Karin Vardy et al. · 2024 · Brain Behavior and Immunity
Amyloid-β Increases Capillary Bed Density in the Adult Zebrafish Retina
Khomthorn P. Cunvong, Daniel Huffmire, Douglas W. Ethell, Donald Joshua Cameron · 2013 · Investigative Ophthalmology & Visual Science
Clinical Applications of a Peptide-Based Vaccine for Glioblastoma
Charles W. Kanaly, Dale Ding, Amy B. Heimberger, John Howard Sampson · 2009 · Neurosurgery Clinics of North America
A Tetra(Ethylene Glycol) Derivative of Benzothiazole Aniline Enhances Ras-Mediated Spinogenesis
Andrea Megill, Taehee Lee, Amanda Marie DiBattista, Jung Min Song, Matthew H. Spitzer, Mark Rubinshtein, Lila K. Habib, Christina C. Capule, Michael Mayer, Raymond Scott Turner et al. · 2013 · Journal of Neuroscience
The neuropathology of Alzheimer's disease in the year 2005
Colin Louis Masters, Konrad T. Beyreuther · 2005 · Cambridge University Press eBooks
Novel therapeutic approach for Alzheimer’s disease by removing amyloid β protein from the brain with an extracorporeal removal system
Kazunori Kawaguchi, Nobuya Kitaguchi, Shigeru Nakai, Kazutaka Murakami, Kunihiko Asakura, Tatsuro Mutoh, Yoshiro Fujita, Satoshi Sugiyama · 2010 · Journal of Artificial Organs
Thermodynamic Studies on the Interaction of Antibodies with β-Amyloid Peptide
Manfred Brockhaus, Peter Ganz, Walter Huber, Bernd Bohrmann, Hansruedi Loetscher, Joachim Seelig · 2007 · The Journal of Physical Chemistry B
Immunotherapy for Alzheimer's disease and other dementias
Delphine Boche, James A. R. Nicoll, Roy O. Weller · 2005 · Current Opinion in Neurology
Vaccination Strategies for Alzheimer???s Disease
Adele Woodhouse, Tracey C. Dickson, James Clement Vickers · 2007 · Drugs & Aging
Effect of age on the duration and extent of amyloid plaque reduction and microglial activation after injection of anti‐Aβ antibody into the third ventricle of TgCRND8 mice
Neelima B. Chauhan, George J. Siegel, Terry Lichtor · 2004 · Journal of Neuroscience Research
Species-specific immune response to immunization with human versus rodent Aβ peptide
Timothy J. Seabrook, Jeanne K. Bloom, Melitza Iglesias, Edward T Spooner, Dominic M. Walsh, Cynthia Ann Lemere · 2004 · Neurobiology of Aging
Phospholipase Cγ2 regulates endocannabinoid and eicosanoid networks in innate immune cells
Jing, Hui, Reed, Alex, Ulanovskaya, Olesya A., Grigoleit, Jan-Sebastian, Herbst, Dylan M., Henry, Cassandra L., Li, Haoxin, Barbas, Sabrina, Germain, Jason, Masuda, Kim et al. · 2021 · Proceedings of the National Academy of Sciences
Immunotherapy for Prion Diseases: Opportunities and Obstacles
Li Li, Scott Napper, Neil R. Cashman · 2010 · Immunotherapy
The role of astrocytes in prion-like mechanisms of neurodegeneration
Phillip Smethurst, Hannah Franklin, Benjamin E. Clarke, Katie C. L. Sidle, Rickie Patani · 2021 · Brain
Pharmacodynamics of Cholinesterase Inhibitors Suggests Add-on Therapy with a Low-Dose Carbamylating Inhibitor in Patients on Long-Term Treatment with Rapidly Reversible Inhibitors
Taher Darreh‐Shori, Sh Makvand Hosseini, Agneta K. Nordberg · 2014 · Journal of Alzheimer s Disease
Developing Novel Immunogens for an Effective, Safe Alzheimer’s Disease Vaccine
Marcel Maier, Timothy J. Seabrook, Cynthia Ann Lemere · 2005 · Neurodegenerative Diseases
Role of Biochemical Alzheimer's Disease Biomarkers as End Points in Clinical Trials
Eric Siemers, Ronald Bradley Demattos, Patrick C. May, Robert A. Dean · 2010 · Biomarkers in Medicine
Clinical Observations with AN-1792 Using TAPIR Analyses
Christoph Höck, Roger M. Nitsch · 2005 · Neurodegenerative Diseases
Boosting with intranasal dendrimeric Aβ1–15 but not Aβ1–15 peptide leads to an effective immune response following a single injection of Aβ1–40/42 in APP-tg mice
Timothy J. Seabrook, Liying Jiang, Katelyn Thomas, Cynthia Ann Lemere · 2006 · Journal of Neuroinflammation
Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies
Maxime Hallé, Pascale Tribout-Jover, Anne-Marie Lanteigne, Jonathan Boulais, Julien R. St-Jean, Rachel Jodoin, Marie‐Pier Girouard, Florin Constantin, Annik Migneault, Frédéric Renaud et al. · 2015 · Journal of Immunological Methods
Mechanism-based treatments for Alzheimer's disease
Peter Davies, Jeremy L. Koppel · 2009 · Dialogues in Clinical Neuroscience
A β -Immunotherapy for Alzheimer's Disease Using Mannan–Amyloid-Beta Peptide Immunoconjugates
Anahit Ghochikyan, Irina Petrushina, Andrew Lees, Vitaly Vasilevko, Nina Movsesyan, Adrine Karapetyan, Michael G. Agadjanyan, David H. Cribbs · 2006 · DNA and Cell Biology
Clinical immunologic approaches for the treatment of Alzheimer's disease
Solomon, Beka · 2007 · Expert Opinion on Investigational Drugs
Molecular Therapeutics in Development to Treat Alzheimer’s Disease
Maria Carmela Tartaglia, Martin Ingelsson · 2024 · Molecular Diagnosis & Therapy
Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice
Hiroki Takeuchi, Keiko Imamura, Bin Ji, Kayoko Tsukita, Takako Enami, Keizo Takao, Tsuyoshi Miyakawa, Masato Hasegawa, Naruhiko Sahara, Nobuhisa Iwata et al. · 2020 · npj Vaccines
Gene Therapy for Parkinsons and Alzheimers Diseases: from the Bench to Clinical Trials
Rui Jorge Nobre, Luís Pereira de Almeida · 2011 · Current Pharmaceutical Design
Vaccines against non-communicable diseases
Till A. Röhn, Martin F. Bachmann · 2010 · Current Opinion in Immunology
An Oral Aβ Vaccine Using a Recombinant Adeno-Associated Virus Vector in Aged Monkeys: Reduction in Plaque Amyloid and Increase in Aβ Oligomers
Hideo Hara, Fumiko Ono, Shinichiro Nakamura, Shin‐ei Matsumoto, Haifeng Jin, Nobutaka Hattori, Takeshi Tabira · 2016 · Journal of Alzheimer s Disease
The PPAR‐γ Agonist 15‐Deoxy‐Δ12,14‐Prostaglandin J2 Attenuates Microglial Production of IL‐12 Family Cytokines: Potential Relevance to Alzheimer′s Disease
Jihong Xu, Steven W. Barger, Paul D. Drew · 2008 · PPAR Research
Molecular basis of Alzheimer’s disease
Anastasia P. Grigorenko, Evgeny Ivanovich Rogaev · 2007 · Molecular Biology
Longitudinal noninvasive magnetic resonance imaging of brain microhemorrhages in BACE inhibitor–treated APP transgenic mice
Nicolau Beckmann, Arno Doelemeyer, Stefan Zurbruegg, Karine Bigot, Diethilde J Theil, Wilfried Frieauff, Carine Kolly, Pierre Moulin, Daniel Neddermann, Robert Kreutzer et al. · 2016 · Neurobiology of Aging
An unconventional hypothesis of oxidation in alzheimer's disease: intersections with excitotoxicity
Steven W. Barger · 2004 · Frontiers in bioscience
Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of Dementia
Laura B. Eisenmenger, Eugene J. Huo, John M. Hoffman, Satoshi Minoshima, Manuela Cristina Matesan, David H. Lewis, Brian J. Lopresti, Chester A. Mathis, David O. Okonkwo, James M. Mountz · 2015 · Seminars in Nuclear Medicine